Octapharma在美国圣迭戈召开的美国血液科学会(ASH)年会上呈报NuProtect研究中既往未曾治疗的患者接受Nuwiq®的关键数据
瑞士拉亨 (美国商业资讯) — 2016年12月4日(周日),Octapharma在加州圣迭戈召开的ASH第58届年会暨展会上呈报了进行中的3期研究NuProtect的中期数据。该呈报被提名收录在2017年ASH北美路演集锦中,其摘要发表于《血液》杂志(Raina Liesner et al, Blood 2016 128:327)。NuProtect研究探寻人类细胞系衍生重组FVIII...
View ArticleCORRECTING and REPLACING ReSound and Cochlear Bimodal Hearing Solutions...
NEW SOUTH WALES, Australia Please replace the release dated December 21, 2016 with the following corrected version due to multiple revisions. The previous version featured a typo in the product name...
View Articleオクタファルマ、発展途上国の血友病A患者が利用できるようNuwiq®をWFH人道支援プログラムに寄付
スイス・ラッヘン (ビジネスワイヤ) — オクタファルマは、当社の第4世代ヒト細胞株由来組み換え型第VIII因子製剤(Nuwiq®)450万ユニットを世界血友病連盟(WFH)の人道支援プログラムに慈善活動として寄付したとことを発表します。...
View ArticleOctapharma向WFH人道主义援助项目捐赠Nuwiq®,使发展中国家的血友病A患者能够得到治疗
瑞士拉亨 (美国商业资讯) — Octapharma自豪地宣布,该公司已向世界血液科联盟(WFH)人道主义援助项目捐赠了450万份Nuwiq®,Nuwiq®是该公司的第四代人类细胞系衍生重组第VIII因子产品。...
View ArticleKubota Pharmaceutical Holdings Signs Letter of Intent to Form a Joint Venture...
TOKYO Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596, “Kubota Pharma”), a clinical-stage ophthalmology company committed to translating innovation into a diverse portfolio of drugs and devices...
View ArticleMizuho OSI’s Insite Specialty Surgical Table Proved Vital in the Separation...
UNION CITY, Calif. Mizuho OSI®, manufacturer of specialty surgical tables, pressure management solutions, and table specific patient care kits, recently fulfilled an urgent and unusual request from...
View ArticleMasimo Reaffirms Commitment to India with Launch of Advanced Monitoring...
BANGALORE, India Masimo (NASDAQ: MASI) announced today the launch and availability of the Rad-97™ Pulse-CO Oximeter®* and Next Generation SedLine®* Brain Function Monitoring in India. The...
View ArticleCellMax Life Takes Liquid Biopsy to Next Level with 73 Gene Profile ctDNA...
SUNNYVALE, Calif. CellMax Life, the precision cancer testing company, announced today the commercial availability of CellMax-LBx Liquid Biopsy in India. CellMax-LBx is a cancer blood test which...
View ArticleBridgeBio Pharma成立,专注于治疗基因疾病的精准药物
加州帕罗奥图 (美国商业资讯) — 总部位于加州的BridgeBio Pharma已走出隐身模式,以披露有关其开发治疗基因疾病新药创新之道的更多细节。这些疾病通常具有遗传性和个体罕见性,整体而言,单在美国就有数千万名病患受到此类疾病的摧残,其中许多是儿童。公司成立于2015年,主要重点是上市前产品,运用其采购和运营优势,在开发的各个阶段寻找和构建价值。 BridgeBio...
View ArticleGI Dynamics, Inc., Appoints Oern R. Stuge, MD, Amid Change to Company’s Board...
BOSTON & SYDNEY GI Dynamics, Inc. (ASX:GID), a medical device company that has developed an innovative device to improve outcomes for patients diagnosed with type 2 diabetes and obesity, today...
View ArticleLombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP...
OXFORDSHIRE, England Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced approval from...
View ArticleTerumo Chooses Xenex LightStrike Germ-Zapping Robots to Disinfect Healthcare...
SAN ANTONIO & TOKYO Terumo Corporation, one of the world’s leading medical device manufacturers and distributors, and Xenex Disinfection Services, the market leader in ultraviolet (UV) room...
View ArticleTakeda and PvP Biologics Announce Development Agreement around Novel...
OSAKA, Japan & SAN DIEGO & SEATTLE Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) and PvP Biologics, Inc. (“PvP”) today announced a global agreement for the development of...
View ArticleMasimo重申对印度市场的承诺,推出专为印度打造的先进监护技术
印度班加罗尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布在印度推出并发售Rad-97™脉搏碳氧氧饱和度仪®*和下一代SedLine®*脑功能监护仪。该消息是Masimo创始人、首席执行官Joe Kiani在班加罗尔召开的班加罗尔顶级医院院长圆桌会议上宣布的。 Masimo创始人、首席执行官Joe...
View Article武田薬品とPvP Biologicsによるセリアック病治療薬の開発に関する提携契約の締結について
大阪 & サンディエゴ & シアトル (ビジネスワイヤ) — 武田薬品工業株式会社(本社:大阪市中央区、以下「武田薬品」)とPvP Biologics,...
View Articleマシモがインド向けの高度なモニタリング技術の市場投入により同国へのコミットメントを再確認
印バンガロール (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、Rad-97™ Pulse-CO...
View ArticleMinomic Announces Clinical Study Update for MILGa in Prostate, Bladder and...
SYDNEY Minomic International Ltd (Minomic) is an immuno-oncology company specializing in therapeutics and diagnostics for solid tumors, including prostate, bladder and pancreas. The Company today...
View ArticleLFB S.A.今天宣布,美国食品药品管理局已受理该公司递交的重组凝血VIIa因子(活化β eptacog)生物制剂许可证申请
法国于利斯 (美国商业资讯) — LFB S.A.宣布,美国食品药品管理局(FDA)已受理该公司的生物制剂许可证申请(BLA),该BLA申报(重组)凝血VIIa因子的上市核准,该因子用于治疗先天性血友病A或B青少年及伴有抑制因子的成人先天性血友病A或B患者。该BLA包含全球性PERSEPT(Program for the Evaluation of Recombinant Factor...
View ArticleTakeda to Acquire ARIAD Pharmaceuticals, Inc.
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) today announced that they have entered into a...
View Article